Search Result "CYP2D6 genotype."
Challenges in CYP2D6 Phenotype Assignment from Genotype Data: A Critical Assessment and Call for Standardization
Journal: Current Drug Metabolism
Volume: 15 Issue: 2 Year: 2014 Page: 218-232
Author(s): J. Kevin Hicks,Jesse J. Swen,Andrea Gaedigk
Genetic Polymorphisms of CYP2D6: Prevalence in Healthy Kurds
Journal: Current Pharmacogenomics and Personalized Medicine
Volume: 17 Issue: 1 Year: 2020 Page: 40-47
Author(s): Muslih Abdulkarim Ibrahim,Zalina Zahari,Nurfadhlina Musa,Khoo Boon Yin
Differences in MDR1 (C3435T), CYP2D6, and CYP1A2 Genotype Frequencies between Patients with Treatment Failure to Antipsychotics and Healthy Russian Population
Journal: Current Pharmacogenomics and Personalized Medicine
Volume: 17 Issue: 1 Year: 2020 Page: 55-63
Author(s): Tatiana Zhiganova,Radkova Eugenia,Sergeeva Tatiana,Volovnikova Viktoriia
Potential Minor Haplotypes of CYP2D6 in the Japanese Population
Journal: Drug Metabolism Letters
Volume: 11 Issue: 1 Year: 2017 Page: 53-59
Author(s): Masatoshi Masuda,Tsutomu Fujiwara,Masayuki Matsunaga,Takehisa Matsumaru
Allelic Variations in CYP2D6 Gene and Susceptibility to Cervical Cancer
Journal: Drug Metabolism Letters
Volume: 1 Issue: 4 Year: 2007 Page: 276-280
Author(s): S. Wajid, S. H. Naqvi, A. Juneja, M. Bharadwaj, A. B. Mitra
Genetic Analysis of CYP2D6 Polymorphism in Indian Populations and its Pharmacogenetic Implications
Journal: Current Pharmacogenomics and Personalized Medicine
Volume: 12 Issue: 2 Year: 2014 Page: 123-132
Author(s): Shamima Choudhury,Elizabeth Akam,Sarabjit Mastana
CYP1A1 and CYP2D6 Polymorphisms and Susceptibility to Chronic Myelocytic Leukaemia
Journal: Current Cancer Drug Targets
Volume: 20 Issue: 9 Year: 2020 Page: 675-680
Author(s): Hadeil M.E. Idris,Hiba B. Khalil,Jeremy Mills,Abozer Y. Elderdery
Difference in Desipramine Metabolic Profile Between Wild-Type and CYP2D6-Humanized Mice
Journal: Drug Metabolism Letters
Volume: 3 Issue: 4 Year: 2009 Page: 234-241
Author(s): Hong-Wu Shen, Ai-Ming Yu
Association of CYP2D6*10 (c. 100 C>T) Genotype with Z-END Concentration in Patients with Breast Cancer Receiving Tamoxifen Therapy in Indonesian Population
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 19 Issue: 8 Year: 2019 Page: 1198-1206
Author(s): Yenny,Sonar S. Panigoro,Denni J. Purwanto,Adi Hidayat,Melva Louisa,Rizka Andalusia,Rianto Setiabudy
Pharmacogenetics of Aromatase Inhibitors in Endocrine Responsive Breast Cancer: Lessons Learnt from Tamoxifen and CYP2D6 Genotyping
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17 Issue: 13 Year: 2017 Page: 1805-1813
Author(s): K.J. Baatjes,M. Conradie,J.P. Apffelstaedt,M.J. Kotze